FindTrial
Sign In

Comparative Study for the Feasibility of a Device for Non-Invasive Clinical Analysis

Comparative Clinical Trial for the Viability of the Progenos® Medical Device

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-58j572j
Enrollment
Unknown
Registered
2024-02-20
Start date
2021-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biomarkers

Interventions

This is a two-arm, double-blind, randomized controlled clinical study. Experimental group: 3000 subjects (men and women) referred for investigation of hematological diseases will collect blood for cli

Sponsors

Nanotimize Tecnologia Ltda.
Lead Sponsor
Nanotimize Tecnologia Ltda.
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Men or women with no age limit; be able to sign the ICF approved by the CEP and execute and understand all study procedures and instructions.

Exclusion criteria

Exclusion criteria: Subjects who do not agree to participate in the clinical trial and do not sign the ICF.

Design outcomes

Primary

MeasureTime frame
Linked to the main aim of this study, the primary outcome is to validate the analytical procedures through multivariate calibration with data obtained by near-infrared spectrophotometry, for the non-invasive quantitative determination of biomarkers of therapeutic interest.—

Secondary

MeasureTime frame
As the main result determined for the present study, it is expected primary outcome, to be successful in the non-invasive detection of analytes of medical interest directly in the blood, making use of spectrophotometric techniques in the near infrared region.—

Countries

Brazil

Contacts

Public ContactJosé A Martins

Nanotimize Tecnologia Ltda.

jose.martins@nanotimize.com.br+55(19)39137800

Outcome results

None listed

Source: REBEC (via WHO ICTRP)